Compounds > 1,2,5,8-tetrahydroxy anthraquinone
Page last updated: 2024-08-16

1,2,5,8-tetrahydroxy anthraquinone and fisetin

1,2,5,8-tetrahydroxy anthraquinone has been researched along with fisetin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Strassburg, CP; Tukey, RH1
Balanda, AO; Bdzhola, VG; Briukhovetska, NV; Golub, AG; Gryshchenko, AA; Kotey, IM; Kukharenko, OP; Ostrynska, OV; Yarmoluk, SM1
Chen, T; Chen, Y; Feng, F; Guo, Q; Lin, H; Liu, W; Liu, Z; Qiao, Y; Qu, W; Sun, H; Yang, H1

Reviews

2 review(s) available for 1,2,5,8-tetrahydroxy anthraquinone and fisetin

ArticleYear
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
    Annual review of pharmacology and toxicology, 2000, Volume: 40

    Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic

2000
Small molecule modulators targeting protein kinase CK1 and CK2.
    European journal of medicinal chemistry, 2019, Nov-01, Volume: 181

    Topics: Animals; Casein Kinase I; Casein Kinase II; Drug Discovery; Humans; Molecular Docking Simulation; Protein Kinase Inhibitors; Small Molecule Libraries

2019

Other Studies

1 other study(ies) available for 1,2,5,8-tetrahydroxy anthraquinone and fisetin

ArticleYear
Design and synthesis of novel protein kinase CK2 inhibitors on the base of 4-aminothieno[2,3-d]pyrimidines.
    European journal of medicinal chemistry, 2016, Jun-10, Volume: 115

    Topics: Casein Kinase II; Dose-Response Relationship, Drug; Drug Design; Humans; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Pyrimidines; Structure-Activity Relationship

2016